Clinical Trials Sponsored by PHCC LP

Total 358 results

Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Schizoaffective Disorder | Psychotic Disorder
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

Anxiety Disorders
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States, India, Romania
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.

Bipolar Disorder
Janssen, LP

Completed

Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)

HIV Infections | Cryptosporidiosis

United States
Janssen, LP

Completed

A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS

HIV Infections | Cryptosporidiosis

United States
Janssen, LP

Completed

A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole

HIV Infections | Candidiasis, Oral

United States
Janssen, LP

Completed

A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis

HIV Infections | Histoplasmosis | Blastomycosis

United States
Institut Cancerologie de l'Ouest
PHRC-I

Recruiting

Management of the Lack of Blood Return on a Central Venous Catheter (CVC) Before Chemotherapy (CATAREV-B)

Catheter Dysfunction

France
Centre Leon Berard
PHRC 2007: financial support

Completed

Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm (GAS2PLUS)

Breast Cancer

France
Christian Buske
Amgen; Janssen, LP

Recruiting

Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia (CZAR-1)

Waldenstrom Macroglobulinemia

Austria, Germany, Greece
Singapore General Hospital
Janssen, LP; International Myeloma Foundation

Active, not recruiting

Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma

Multiple Myeloma | Myeloma

Singapore
PETHEMA Foundation
Celgene; Pierre Fabre Medicament; Janssen, LP

Completed

Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old (GEM2012MENOS65)

Multiple Myeloma

Spain
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Schizoaffective Disorder | Psychotic Disorder

United States, India, Malaysia, Romania, Korea, Republic of, Philippines
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

Depressive Disorder | Depression | Depressive Disorder, Major
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder
Georgetown University
Bristol-Myers Squibb; Targovax ASA; Janssen, LP

Recruiting

Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer (DARANIVOVAX)

Pancreatic Ductal Adenocarcinoma | Refractory Non-Small Cell Lung Cancer

United States
Omar Nadeem, MD
Janssen, LP

Recruiting

DARA RVD For High Risk SMM (PRISM)

Multiple Myeloma | High-risk Smoldering Multiple Myeloma

United States
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Janssen, LP

Recruiting

USTekinumab in Fistulising Perianal Crohn's Disease (USTAP) (USTAP)

Crohn's Disease

France
National University Hospital, Singapore
Janssen, LP; International Myeloma Foundation

Unknown

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Relapse and / or Refractory Myeloma

Singapore, Hong Kong, Taiwan, Korea, Republic of
McMaster University
Public Health Agency of Canada (PHAC)

Active, not recruiting

Beyond Silence: Advancing E-mental Health Solutions to Support Canadian Healthcare Workers

Post-traumatic Stress Disorder | Mental Stress | Mental Health Issue | Moral Injury

Canada
Dalhousie University
PHAC/CIHR Influenza Research Network

Completed

Influenza Vaccine Safety and Effectiveness in Healthcare Providers

Influenza
University of California, San Diego
Takeda; Celgene; Janssen, LP

Active, not recruiting

Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

United States
Wake Forest University Health Sciences
Celgene; Amgen; Janssen, LP

Active, not recruiting

Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
University Hospital, Toulouse
Ministry of Health, France; Janssen, LP

Completed

Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma (IFM2014-02)

Multiple Myeloma

France, Belgium
University Hospital, Lille
Janssen, LP; Intergroupe Francophone du Myelome

Completed

Study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple Myeloma (IFM2014-04)

Multiple Myeloma

France, Belgium
Lund University Hospital
Celgene; Janssen, LP; Nordic Lymphoma Group

Completed

A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma (PHILEMON)

Relapsed/Refractory Mantle Cell Lymphoma

Finland, Denmark, Sweden, Norway
French Innovative Leukemia Organisation
Mundipharma Pte Ltd.; Janssen, LP

Completed

Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma (ManteauRiBVD)

Lymphoma

France
Seattle Institute for Biomedical and Clinical Research
Janssen, LP

Completed

A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

United States
University Hospital, Toulouse
Janssen, LP; Ligue contre le cancer, France

Not yet recruiting

Real-life Management of Patients Eligible for CAR-T Cell Therapy (CARAVAGE)

Hemopathy

France
University of California, Los Angeles
American Heart Association; Janssen, LP

Completed

Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

Cardiac Allograft Vasculopathy

United States
Spanish Oncology Genito-Urinary Group
Apices Soluciones S.L.; Janssen, LP

Completed

Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer. (ABIDO)

Metastatic Prostate Cancer

Spain
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Janssen, LP

Completed

Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma

CD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditions

United States
White River Junction Veterans Affairs Medical Center
NormaTec Industries LP

Unknown

Treatment of Claudication With a Peristaltic Pulse Pneumatic Device

Intermittent Claudication

United States
University of Alberta
Public Health Agency of Canada (PHAC)

Completed

Supporting Family Caregivers of Persons Living With Dementia: Effectiveness and Sustainability of MT4C-In Care

Dementia | Family

Canada
University of British Columbia
PHAC/CIHR Influenza Research Network

Completed

Comparison of 4 Influenza Vaccines in Seniors (PCIRNRT09)

Influenza Vaccine

Canada
McMaster University
Public Health Agency of Canada (PHAC)

Completed

e-Learning About Cognitive Impairment and Dementia Prevention

Dementia Prevention

Canada
York University
Public Health Agency of Canada (PHAC)

Unknown

Electronically Connected Health Coaching in Type 2 Diabetes

Type 2 Diabetes

Canada
GI Alliance
Mayo Clinic; University of Wisconsin, Madison; Janssen, LP

Not yet recruiting

Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases

United States
SWOG Cancer Research Network
National Cancer Institute (NCI); Janssen, LP

Recruiting

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)

Multiple Myeloma

United States, Canada
University of British Columbia
Juvenile Diabetes Research Foundation; Janssen, LP

Recruiting

Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2) (UST1D2)

Type 1 Diabetes Mellitus

Canada
Instituto do Cancer do Estado de São Paulo
Janssen, LP

Completed

Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer

Prostate Cancer

Brazil
State University of New York - Downstate Medical...
Janssen, LP

Unknown

PREvent First Episode Relapse (PREFER)

Schizophrenia

United States
University of Calgary
Public Health Agency of Canada (PHAC)

Recruiting

Makoyoh'Sokoi - The Wolf Trail Program Expansion Project - Supporting Indigenous Women to Celebrate Good Health (MKS+)

Physical Inactivity

Canada
University of Calgary
Public Health Agency of Canada (PHAC)

Recruiting

Evaluation of the WiseGuyz Program for Adolescent Boys

Violence, Gender-Based

Canada
Western University, Canada
Public Health Agency of Canada (PHAC)

Terminated

Mind Up (MindUP) Evaluation With Grade 3 Students

Child Development

Canada
University of Guelph
Public Health Agency of Canada (PHAC)

Completed

Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment Study (DRA)

Obesity | Metabolic Syndrome | Dyslipidemia | Type-2 Diabetes

Canada

Clinical Trials Sponsored by PHCC LP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations